Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 123
Filter
1.
PLoS Negl Trop Dis ; 15(8): e0009648, 2021 08.
Article in English | MEDLINE | ID: mdl-34415898

ABSTRACT

BACKGROUND: Cystic echinococcosis (CE) is a complex disease for which clear understanding of clinical manifestations is needed to avoid misdiagnosis, inappropriate treatment, and severe complications. We evaluated the accuracy of a whole-blood stimulation test based on Interleukin (IL)-4 detection in response to Antigen B (AgB) of Echinococcus granulosus sensu lato to discriminate cyst viability and detect cyst reactivation in patients with hepatic CE. METHODOLOGY/PRINCIPAL FINDINGS: Thirty patients with CE3b cysts and 37 patients with spontaneously-inactivated CE4-CE5 cysts were recruited (T0). After enrollment, 5 patients with CE3b cysts received albendazole, resulting in cyst solidification (CE4) in 4/5. Within a two-year follow-up, the whole-blood test was repeated at two time-points, in ≥14 (T1) and in ≥4 (T2) patients per group. IL-4 and a panel of other soluble factors were measured in the stimulated plasma. Baseline IL-4 levels were significantly higher in patients with CE3b compared to those with CE4 cysts (p = 0.006). Test accuracy for CE3b diagnosis had a sensitivity of 33-60% and a specificity of 76-95%, depending on the cut-off applied. Overall, IL-4 levels did not change significantly over time in either group; however, patients within the CE3b group showed a significant decrease of IL-1ra, IL-6, IL-8, G-CSF, IFN-γ, IP-10, MCP-1, MIP-1α, FGF at T1 compared to T0 (p≤0.042). CONCLUSIONS/SIGNIFICANCE: Whole-blood IL-4-response to AgB is significantly higher in patients with active compared to inactive CE but apparently not modulated over time after treatment. On the contrary, the levels of IL-1ra, IL-6, IL-8, G-CSF, IFN-γ, IP-10, MCP-1, MIP-1α, FGF significantly decreased in active CE during follow-up. Additional studies are needed to understand whether these findings might have a clinical significance for patients' follow-up.


Subject(s)
Cysts/immunology , Echinococcosis/blood , Echinococcus granulosus/immunology , Interleukin-4/blood , Adult , Aged , Albendazole/therapeutic use , Animals , Cytokines/blood , Echinococcosis/drug therapy , Female , Hematologic Tests , Humans , Life Cycle Stages/immunology , Male , Middle Aged , Prospective Studies , Treatment Outcome
3.
PLoS One ; 15(10): e0240198, 2020.
Article in English | MEDLINE | ID: mdl-33007021

ABSTRACT

Hypertension frequently occurs in subclinical hypothyroidism (SCH). By bolstering thyroid inflammation, anti-peroxidase antibody (TPO-Ab) causes autoimmune thyroiditis, which is one of the most common causes of SCH. Since the absence of thyroid cysts is associated with TPO-Ab (+) based on the indication of latent thyroid damage, we explored the potential mechanism underlying the association among TPO-Ab, SCH, hypertension, and thyroid cysts. A cross-sectional study of 1,483 Japanese aged 40-74 years was conducted. Thyroid cysts were defined as those having a maximum diameter of ≥ 2.0 mm, containing no solid component. TPO-Ab (+) was positively associated with SCH with hypertension (adjusted odds ratio [OR] and 95% confidence interval [CI], 2.62 [1.40, 4.89]) but not with SCH without hypertension (0.84 [0.37, 1.89]), respectively. Moreover, among participants without thyroid cysts, SCH was positively associated with hypertension (2.15 [1.23, 3.76]) but not among participants with thyroid cysts (0.58 [0.16, 2.16]), respectively. TPO-Ab was positively associated with SCH with hypertension, but not with SCH without hypertension. In addition, status of thyroid cysts might act as a determinant factor on the association between SCH and hypertension. These findings are efficient tools to clarify the background mechanism that underlies SCH.


Subject(s)
Cysts/immunology , Hypertension/immunology , Hypothyroidism/immunology , Iodide Peroxidase/immunology , Thyroid Diseases/immunology , Adult , Aged , Asian People , Autoantibodies/immunology , Cross-Sectional Studies , Female , Humans , Hypertension/complications , Hypothyroidism/complications , Hypothyroidism/enzymology , Male , Middle Aged , Thyroid Diseases/complications
4.
Parasit Vectors ; 13(1): 133, 2020 Mar 14.
Article in English | MEDLINE | ID: mdl-32171321

ABSTRACT

BACKGROUND: Cystic echinococcosis (CE) is a worldwide parasitic zoonosis caused by infection of the larval stage of tapeworm Echinococcus granulosus. In human CE, the parasites develop and form cysts in internal organs. The differentiated cysts can be classified into five types based on WHO-IWGE standard CE1-5 representing different developmental stages. Infection with E. granulosus triggers hosts' humoral and cellular response, displaying elevated serum antibodies and Th1 and Th2 cytokines, which are presumed to be in association with the disease outcome. Identification of immunological markers for evaluation of disease progression has been a growing concern. However, the distinctive profile of cytokines and antibodies associated with the cyst progression has not been ascertained. METHODS: To better understand the interaction between host immune response and disease outcome, the present study followed-up four CE patients over three years by yearly measuring serum level of 27 cytokines, total IgG and isotypes, and ultrasound scanning, beginning in year 1 for all patients with CE1 and CE2 cysts before treatment and continued in year 2 with CE4 and in year 3 with CE3-CE5 post-treatment. RESULTS: Nine cytokines including Th1-type IL-2, Th17-type IL-17A, and inflammatory cytokines IL-1ß, IL-1Rα and TNF-α, chemokines IL-8, MIP-1α, MIP-1ß, and growth factor G-CSF were significantly elevated in patients with cyst type CE1, compared to the normal controls, and then declined to a normal level at CE4 and CE5. Examining the antibody production, we found that serum specific IgG was significantly increased in patients with active and transitional cysts, specifically the total IgG at CE1/CE3/CE4-CE5, IgG4 at CE1 and IgG1 at CE1/CE3 cyst status, in comparison with the normal controls, but showed no significant changes between the cyst stages. CONCLUSIONS: Our findings provide new information on the profile of multiplex cytokines and serum antibodies associated with cyst stages in cystic echinococcosis patients through a three-year follow-up, implying that further studies using an approach combining cyst-associated immune parameters may aid in identifying immunological markers for differentiation of disease progression.


Subject(s)
Antibodies, Protozoan/blood , Cysts/immunology , Cytokines/blood , Echinococcosis/immunology , Echinococcus granulosus/immunology , Aged , Animals , China , Disease Progression , Echinococcosis/diagnosis , Echinococcosis/parasitology , Echinococcosis/therapy , Farmers , Female , Follow-Up Studies , Humans , Immunoglobulin G/blood , Life Cycle Stages/immunology , Male , Middle Aged , Ultrasonography
5.
Urology ; 138: e3-e4, 2020 04.
Article in English | MEDLINE | ID: mdl-31978528

ABSTRACT

Ureteritis cystica is rare, benign entity that associates with chronic urothelial irritation such as recurrent urinary tract infection or nephrolithiasis. It is often diagnosed incidentally on routine imaging or ureteroscopy in asymptomatic individuals. In this case report, we present the retrograde pyelogram and ureteroscopy images of a rare case of extensive unilateral ureteritis cystica in a 78-year-old female presenting for elective stone surgery.


Subject(s)
Cysts/diagnosis , Ureter/pathology , Ureteral Diseases/diagnosis , Urothelium/pathology , Aged , Cysts/immunology , Cysts/pathology , Female , Humans , Ureter/diagnostic imaging , Ureter/immunology , Ureteral Diseases/immunology , Ureteral Diseases/pathology , Ureteroscopy , Urography , Urothelium/diagnostic imaging , Urothelium/immunology
6.
Acta Trop ; 182: 135-143, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29486175

ABSTRACT

To evaluate the relationship between cyst activity and calcification degree in cystic echinococcosis (CE) in humans, 99 hepatic cysts at successive stages of involution, surgically excised from 72 Sardinian patients, have been analyzed. Cysts were classified into 4 groups according to calcification extent: CALC 0 (no calcification); CALC 1 (scattered punctate calcifications); CALC 2 (large coarse segmental/partial calcifications); CALC 3 (complete or nearly complete circumferential ring of calcification up to thick wall of osseous consistency/calcified content of cyst). In addition the possible correlation with antibody response has been explored analyzing IgG1, IgG4 and IgE produced against somatic PSCAg. Results showed that calcification is not restricted to the inactive WHO cyst types CE4 and CE5, but occurs to a varying extent in all morphotypes of metacestode, from active classic unilocular or multivesicular cysts to the more complicated and highly degenerate stages, where cyst wall appears massively calcified. Prevalence of calcification increases with progression of cyst degenerative process, but is not synonymous with parasite inactivity and can be misleading as signs of calcification may coexist with still metabolically active cysts. On the contrary, detection of entirely firmly solidified content seems a reliable indication of cyst inactivity. IgG4 is the dominant isotype associated particularly with the evolutive phase. Positive rates and OD levels, higher in active vs inactive stages, are stable or increase slightly in weakly and moderately calcified cysts (CALC 1/CALC 2), compared to non-calcified ones (CALC 0), strongly decreasing in highly calcified forms (CALC 3). In conclusion, evaluation of calcification extent may be pertinent for staging CE, and immunological tests, particularly for IgG4, and IgE may help to better define cyst activity.


Subject(s)
Calcinosis/pathology , Cysts/pathology , Echinococcosis, Hepatic/pathology , Adolescent , Adult , Aged , Calcinosis/immunology , Calcinosis/parasitology , Child , Child, Preschool , Cysts/immunology , Cysts/parasitology , Disease Progression , Echinococcosis, Hepatic/immunology , Female , Humans , Immunoglobulin G/immunology , Infant , Infant, Newborn , Liver/immunology , Liver/parasitology , Liver/pathology , Male , Middle Aged , Young Adult
7.
J Pediatr Endocrinol Metab ; 30(7): 781-784, 2017 Jul 26.
Article in English | MEDLINE | ID: mdl-28672775

ABSTRACT

BACKGROUND: Polycystic thyroid disease (PCTD) is a rare condition and has been described in adults in the setting of subclinical and clinical hypothyroidism. We present the first known case of a pediatric patient with diffuse macrocystic degeneration of the thyroid. CLINICAL PRESENTATION: A 6-year-old previously healthy patient was evaluated after presenting with a 16-month history of an enlarging polycystic thyroid and hyperthyroidism. Markers of autoimmune thyroid disease including thyroid stimulating immunoglobulin (TSI), thyroid stimulating hormone (TSH) receptor antibody, thyroid peroxidase antibody and thyroglobulin antibody were negative. No family history of benign or malignant thyroid or cystic disease was present. The patient underwent a total thyroidectomy without perioperative complication. She remains euthyroid with thyroid hormone replacement therapy. SUMMARY: To our knowledge, this is the first report of PCTD in the pediatric population associated with hyperthyroidism without evidence of autoimmune disease. Somatic activating thyrotropin-receptor gene mutations are known to cause non-autoimmune hyperthyroidism in children, however it is unknown if similar mechanisms are responsible for pediatric PCTD. CONCLUSIONS: Polycystic thyroid degeneration can occur in children and may result in a hyperthyroid state.


Subject(s)
Autoantibodies/immunology , Cysts/pathology , Thyroid Diseases/pathology , Child , Cysts/immunology , Female , Humans , Prognosis , Thyroid Diseases/immunology
8.
Trends Parasitol ; 33(2): 93-101, 2017 02.
Article in English | MEDLINE | ID: mdl-27939103

ABSTRACT

It is believed that infection by Toxoplasma gondii triggers a lifelong protective immunity due to the persistence of parasitic cysts which induce immunoprotection against reinfection. A review of the scientific literature since the 1950s did not yield any definitive data regarding the duration of cysts in the host or the presence of lifelong protective immunity, which led us to question this dogma. We put forward the hypothesis that sustained immunity to T. gondii requires repeated antigenic stimulations. The decline of seroprevalence recently observed in many countries might contribute to explain the loss of immunity. We address the potential consequences of this phenomenon, should it persist and worsen.


Subject(s)
Cysts/immunology , Host-Parasite Interactions/immunology , Toxoplasma/immunology , Toxoplasmosis/immunology , Antibodies, Protozoan/blood , Antibodies, Protozoan/immunology , Brain/parasitology , Humans , Periodicals as Topic
9.
Auris Nasus Larynx ; 44(1): 126-130, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27264875

ABSTRACT

We present two cases of an HIV-associated parotid gland cyst. One case was a 36-year-old HIV infected woman. She was diagnosed with HIV infection and presented with slowly enlarged parotid gland cysts together with elevation of HIV viral RNA copies/mL in her serum. She was performed parotid gland biopsy under the general anesthesia. The histopathologic analysis revealed negative HIV p24-antigen in her parotid gland tissue. The other case was a 43-year-old man found his parotid gland swelling shortly after highly active antiretroviral therapy (HAART). He was diagnosed with HIV infection 2 years previously. He had started HAART several days before. He showed exceeding elevation of IgE in his serum. We treated him with medication using anti-histamic drugs for his cyst. A computed tomography scan revealed a complete response of his parotid gland cyst 4 weeks after the medication. His serum IgE level was decreased to half of the level before the medication. These findings suggested that the parotid gland swelling associated with HIV was due to various factors including immune reconstitution inflammatory syndrome (IRIS). In case such a parotid gland swelling, we could avoid invasive treatments.


Subject(s)
Cysts/immunology , HIV Infections/immunology , Immune Reconstitution Inflammatory Syndrome/immunology , Immunoglobulin E/immunology , Parotid Diseases/immunology , Adult , Antiretroviral Therapy, Highly Active , Cysts/complications , Cysts/diagnostic imaging , Cysts/drug therapy , Female , HIV Core Protein p24/metabolism , HIV Infections/complications , HIV Infections/drug therapy , HIV Infections/metabolism , Histamine Antagonists/therapeutic use , Humans , Male , Parotid Diseases/complications , Parotid Diseases/diagnostic imaging , Parotid Diseases/drug therapy , RNA, Viral/metabolism , Tomography, X-Ray Computed
10.
Brain Behav Immun ; 58: 52-56, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27109609

ABSTRACT

Exposure to the neurotropic parasite, Toxoplasma gondii, causes significant brain and behavioral anomalies in humans and other mammals. Understanding the cellular mechanisms of T. gondii-generated brain pathologies would aid the advancement of novel strategies to reduce disease. Complement factor C1q is part of a classic immune pathway that functions peripherally to tag and remove infectious agents and cellular debris from circulation. In the developing and adult brain, C1q modifies neuronal architecture through synapse marking and pruning. T. gondii exposure and complement activation have both been implicated in the development of complex brain disorders such as schizophrenia. Thus, it seems logical that mechanistically, the physiological pathways associated with these two factors are connected. We employed a rodent model of chronic infection to investigate the extent to which cyst presence in the brain triggers activation of cerebral C1q. Compared to uninfected mice, cortical C1q was highly expressed at both the RNA and protein levels in infected animals bearing a high cyst burden. In these mice, C1q protein localized to cytoplasm, adjacent to GFAP-labeled astrocytes, near degenerating cysts, and in punctate patterns along processes. In summary, our results demonstrated an upregulation of cerebral C1q in response to latent T. gondii infection. Our data preliminarily suggest that this complement activity may aid in the clearance of this parasite from the CNS and in so doing, have consequences for the connectivity of neighboring cells and synapses.


Subject(s)
Cerebral Cortex/immunology , Cerebral Cortex/parasitology , Complement C1q/metabolism , Toxoplasmosis/immunology , Animals , Chronic Disease , Cysts/immunology , Female , Mice
12.
Mol Biochem Parasitol ; 202(1): 22-8, 2015 Jul.
Article in English | MEDLINE | ID: mdl-26341468

ABSTRACT

Human and porcine cysticercosis is caused by the larval stage of the flatworm Taenia solium (Cestoda). The protein extracts of T. solium cysts are complex mixtures including cyst's and host proteins. Little is known about the influence of using different detergents in the efficiency of solubilization-extraction of these proteins, including relevant antigens. Here, we describe the use of CHAPS, ASB-14 and Triton X-100, alone or in combination in the extraction buffers, as a strategy to notably increase the recovery of proteins that are usually left aside in insoluble fractions of cysts. Using buffer with CHAPS alone, 315 protein spots were detected through 2D-PAGE. A total of 255 and 258 spots were detected using buffers with Triton X-100 or ASB-14, respectively. More protein spots were detected when detergents were combined, i.e., 2% CHAPS, 1% Triton X-100 and 1% ASB-14 allowed detection of up to 368 spots. Our results indicated that insoluble fractions of T. solium cysts were rich in antigens, including several glycoproteins that were sensitive to metaperiodate treatment. Host proteins, a common component in protein extracts of cysts, were present in larger amounts in soluble than insoluble fractions of cysts proteins. Finally, antigens present in the insoluble fraction were more appropriate as a source of antigens for diagnostic procedures.


Subject(s)
Antigens, Helminth/isolation & purification , Cysts/chemistry , Detergents/chemistry , Taenia solium/chemistry , Animals , Antigens, Helminth/immunology , Betaine/analogs & derivatives , Betaine/chemistry , Buffers , Cholic Acids/chemistry , Cysts/immunology , Cysts/parasitology , Electrophoresis, Gel, Two-Dimensional/methods , Glycoproteins/isolation & purification , Humans , Muscle, Skeletal/parasitology , Swine , Taenia solium/immunology , Taeniasis/parasitology
13.
PLoS Negl Trop Dis ; 9(3): e0003577, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25774662

ABSTRACT

Cysticidal treatment of neurocysticercosis, an infection of humans and pig brains with Taenia solium, results in an early inflammatory response directed to cysts causing seizures and focal neurological manifestations. Treatment-induced pericystic inflammation and its association with blood brain barrier (BBB) dysfunction, as determined by Evans blue (EB) extravasation, was studied in infected untreated and anthelmintic-treated pigs. We compared the magnitude and extent of the pericystic inflammation, presence of EB-stained capsules, the level of damage to the parasite, expression of genes for proinflammatory and regulatory cytokines, chemokines, and tissue remodeling by quantitative PCR assays between treated and untreated infected pigs and between EB-stained (blue) and non stained (clear) cysts. Inflammatory scores were higher in pericystic tissues from EB-stained cysts compared to clear cysts from untreated pigs and also from anthelmintic-treated pigs 48 hr and 120 hr after treatment. The degree of inflammation correlated with the severity of cyst wall damage and both increased significantly at 120 hours. Expression levels of the proinflammatory genes for IL-6, IFN-γ, TNF-α were higher in EB-stained cysts compared to clear cysts and unaffected brain tissues, and were generally highest at 120 hr. Additionally, expression of some markers of immunoregulatory activity (IL-10, IL-2Rα) were decreased in EB-stained capsules. An increase in other markers for regulatory T cells (CTLA4, FoxP3) was found, as well as significant increases in expression of two metalloproteases, MMP1 and MMP2 at 48 hr and 120 hr post-treatment. We conclude that the increase in severity of the inflammation caused by treatment is accompanied by both a proinflammatory and a complex regulatory response, largely limited to pericystic tissues with compromised vascular integrity. Because treatment induced inflammation occurs in porcine NCC similar to that in human cases, this model can be used to investigate mechanisms involved in host damaging inflammatory responses and agents or modalities that may control damaging post treatment inflammation.


Subject(s)
Brain Diseases/immunology , Cysts/immunology , Inflammation/etiology , Neurocysticercosis/immunology , Swine Diseases/immunology , Animals , Anthelmintics/therapeutic use , Brain Diseases/veterinary , Capillary Permeability , Cysts/veterinary , Evans Blue/metabolism , Neurocysticercosis/drug therapy , Neurocysticercosis/metabolism , Neurocysticercosis/veterinary , Swine , Swine Diseases/drug therapy , Swine Diseases/metabolism
14.
World J Gastroenterol ; 20(43): 16355-8, 2014 Nov 21.
Article in English | MEDLINE | ID: mdl-25473195

ABSTRACT

A ciliated hepatic foregut cyst (CHFC) is a rare foregut developmental malformation usually diagnosed in adulthood. Five percent of reported cases of CHFC transform into squamous cell carcinoma. We report the presentation, evaluation, and surgical management of a symptomatic 45-year-old male found to have a 6.2 cm CHFC. Contrast tomography-guided fine-needle aspiration demonstrated columnar, ciliated epithelium consistent with the histologic diagnosis of CHFC. The intracystic levels of carbohydrate antigen (CA) 19-9 and carcinoembryonic antigen (CEA) were extremely high (978118 U/mL and 973 µg/L, respectively). Histologically, the wall of the cyst showed characteristic pseudopapillae lined with a ciliated stratified columnar epithelium, underlying smooth muscle, an outer fibrous layer and no atypia. Immunohistochemistry for CA19-9 and CEA was positive. This is the first case report of a CHFC in which levels of CA 19-9 and CEA were measured. Our findings suggest that a large sized multilocular cyst and elevated cyst CA19-9 and CEA levels do not exclude a CHFC from consideration in the diagnosis. CHFCs should be included in the differential diagnosis of hepatic lesions. Accurate diagnosis of a CHFC is necessary given its potential for malignant transformation, and surgical excision is recommended.


Subject(s)
CA-19-9 Antigen/analysis , Cysts/immunology , Epithelial Cells/immunology , Liver Diseases/immunology , Biomarkers/analysis , Biopsy, Fine-Needle , Carcinoembryonic Antigen/analysis , Cilia/pathology , Cysts/congenital , Cysts/diagnosis , Cysts/surgery , Diagnosis, Differential , Epithelial Cells/pathology , Humans , Image-Guided Biopsy/methods , Immunohistochemistry , Liver Diseases/congenital , Liver Diseases/diagnosis , Liver Diseases/surgery , Magnetic Resonance Imaging , Male , Middle Aged , Predictive Value of Tests , Tomography, X-Ray Computed , Treatment Outcome , Up-Regulation
15.
JAMA Ophthalmol ; 131(7): 929-32, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23846204

ABSTRACT

IMPORTANCE: Lacrimal gland ductal cysts (dacryops) are uncommon, occurring anywhere that lacrimal gland tissue is present. While dacryops has long been recognized, its pathogenesis has not been well established. OBSERVATIONS: Five cases of dacryops were identified at the Ottawa Hospital over a 3-year period (2009-2012). Histopathological examination showed immunoreactivity to IgA on the luminal surface of the epithelial ductal cyst and mild chronic inflammation in the underlying stroma or lacrimal gland. CONCLUSIONS AND RELEVANCE: Our results suggest that a multifactorial mechanism leads to dacryops including chronic inflammation, an immune response, and IgA hypersecretion with an osmotic effect, all contributing to the cyst formation. Further research on the pathogenesis is recommended.


Subject(s)
Cysts/etiology , Lacrimal Apparatus Diseases/etiology , Aged , Child, Preschool , Cysts/diagnosis , Cysts/immunology , Dacryocystitis/diagnosis , Female , Humans , Immunoenzyme Techniques , Immunoglobulin A/immunology , Lacrimal Apparatus Diseases/diagnosis , Lacrimal Apparatus Diseases/immunology , Male , Middle Aged , Tomography, X-Ray Computed
16.
Histopathology ; 62(7): 1067-74, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23614399

ABSTRACT

AIMS: Cystic lymphoid hyperplasia (CLH) frequently affects the parotid gland in human immunodeficiency virus (HIV)-infected patients. This clinicopathological study, comprising 167 cases, aims to define the clinical-pathological parameters of CLH in order to elucidate the aetiopathogenesis. METHODS AND RESULTS: This retrospective study of 167 archival cases of CLH recorded patients' age, race and gender, and the nature, site and symptoms of CLH. A total of 109 cases were reviewed histologically and analyzed for HIV-1 p24 antigen immunopositivity using standard procedures. CLH of the parotid gland showed a male predominance, whereas submandibular gland (P = 0.27) and bilateral parotid involvement favoured females (2:1). CLH occurred at a younger mean age in females than males in the parotid gland (P = 0.0035) and in the submandibular gland (P = 0.0032). Intra-lymph nodal origin was favoured, with 76.1% of cases occurring within entrapped salivary gland remnants. P24 staining revealed ~90% sensitivity in HIV-associated CLH. CONCLUSION: CLH should be used preferentially to describe parotid enlargement in HIV-infected patients. This study strongly supports the hypothesis that CLH develops following ductal ectasia of entrapped salivary gland inclusions arising within lymph nodes. CLH should be classified as an orofacial lesion associated strongly with HIV and AIDS.


Subject(s)
Acquired Immunodeficiency Syndrome/pathology , Cysts/pathology , HIV Core Protein p24/immunology , Parotid Gland/pathology , Submandibular Gland/pathology , Acquired Immunodeficiency Syndrome/immunology , Adolescent , Adult , Age Factors , Aged , Child , Cysts/immunology , Female , Humans , Hyperplasia , Lymph Nodes/metabolism , Lymph Nodes/pathology , Lymphocytes/pathology , Male , Middle Aged , Parotid Gland/metabolism , Retrospective Studies , Submandibular Gland/metabolism , Young Adult
17.
Eur J Obstet Gynecol Reprod Biol ; 168(2): 187-90, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23351670

ABSTRACT

OBJECTIVE: To evaluate 8-hydroxy-2-deoxyguanosine (8-OHdG) and 8-isoprostane levels in the peritoneal fluid (PF) of women with endometriosis. STUDY DESIGN: One hundred and ten women with laparoscopically and histopathologically confirmed endometriosis and, as reference groups, 119 patients with simple serous (n=78) and dermoid (n=41) ovarian cysts were studied. Peritoneal fluid 8-OHdG and 8-isoprostane concentrations were evaluated by enzyme-linked immunosorbent assays. RESULTS: 8-OHdG and 8-isoprostane levels in peritoneal fluid were significantly higher in patients with endometriosis compared with the reference groups. Higher PF 8-OHdG and 8-isoprostane concentrations were observed in patients with advanced stages of endometriosis. A statistically significant positive correlation was found between 8-OHdG and 8-isoprostane levels in peritoneal fluid. CONCLUSION: Endometriosis induces greater oxidative stress and frequent DNA mutations in peritoneal fluid than nonendometriotic ovarian cysts. The most severe oxidative stress occurs in the peritoneal cavity of women with more advanced stages of the disease.


Subject(s)
Ascitic Fluid/metabolism , Deoxyguanosine/analogs & derivatives , Dinoprost/analogs & derivatives , Endometriosis/pathology , Ovarian Cysts/pathology , Oxidative Stress , Up-Regulation , 8-Hydroxy-2'-Deoxyguanosine , Adolescent , Adult , Biomarkers/metabolism , Cysts/immunology , Cysts/metabolism , Cysts/pathology , Cysts/physiopathology , Deoxyguanosine/metabolism , Dermoid Cyst/immunology , Dermoid Cyst/metabolism , Dinoprost/metabolism , Endometriosis/immunology , Endometriosis/metabolism , Endometriosis/physiopathology , Female , Humans , Middle Aged , Mutation , Ovarian Cysts/immunology , Ovarian Cysts/metabolism , Ovarian Cysts/physiopathology , Ovarian Neoplasms/immunology , Ovarian Neoplasms/metabolism , Peritoneum/immunology , Peritoneum/metabolism , Peritoneum/pathology , Peritoneum/physiopathology , Severity of Illness Index , Young Adult
18.
PLoS Pathog ; 8(11): e1002990, 2012.
Article in English | MEDLINE | ID: mdl-23209401

ABSTRACT

Chronic infections represent a continuous battle between the host's immune system and pathogen replication. Many protozoan parasites have evolved a cyst lifecycle stage that provides it with increased protection from environmental degradation as well as endogenous host mechanisms of attack. In the case of Toxoplasma gondii, these cysts are predominantly found in the immune protected brain making clearance of the parasite more difficult and resulting in a lifelong infection. Currently, little is known about the nature of the immune response stimulated by the presence of these cysts or how they are able to propagate. Here we establish a novel chitinase-dependent mechanism of cyst control in the infected brain. Despite a dominant Th1 immune response during Toxoplasma infection there exists a population of alternatively activated macrophages (AAMØ) in the infected CNS. These cells are capable of cyst lysis via the production of AMCase as revealed by live imaging, and this chitinase is necessary for protective immunity within the CNS. These data demonstrate chitinase activity in the brain in response to a protozoan pathogen and provide a novel mechanism to facilitate cyst clearance during chronic infections.


Subject(s)
Brain Diseases/immunology , Brain/immunology , Macrophages/immunology , Th1 Cells/immunology , Toxoplasma/immunology , Toxoplasmosis/immunology , Animals , Brain/microbiology , Brain/pathology , Brain Diseases/microbiology , Brain Diseases/pathology , Chitinases/immunology , Cysts/immunology , Cysts/pathology , Macrophages/pathology , Mice , Th1 Cells/pathology , Toxoplasmosis/pathology
19.
S Afr J Surg ; 50(3): 92, 2012 Jul 11.
Article in English | MEDLINE | ID: mdl-22856444

ABSTRACT

BACKGROUND: Peliosis is a rare condition characterised by multiple cyst-like, blood-filled cavities within the parenchyma of solid organs, most commonly affecting the liver. Isolated splenic peliosis is an even more unusual phenomenon. Patients with AIDS may develop peliosis in association with bacillary angiomatosis. This is due to secondary infection with Bartonella henselae or a similar organism, Rochalimaea henselae. CASE PRESENTATION: A 45-year-old HIV-positive man on antiretroviral therapy presented with a left hypochodrial abdominal mass. Radiological and histopathological examination confirmed splenic peliosis.


Subject(s)
Cysts/diagnosis , Cysts/surgery , HIV Seropositivity , Immunocompromised Host , Splenic Diseases/diagnosis , Splenic Diseases/surgery , Vascular Diseases/diagnosis , Vascular Diseases/surgery , Contrast Media , Cysts/immunology , Diagnosis, Differential , Humans , Male , Middle Aged , Splenectomy , Splenic Diseases/immunology , Tomography, X-Ray Computed , Vascular Diseases/immunology
20.
Thorac Cardiovasc Surg ; 59(4): 255-6, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21409752

ABSTRACT

Pulmonary tuberculosis (TB) is a medical and social problem, particularly in developing countries. Early diagnosis and treatment is important. Chest radiography is usually the first diagnostic tool when there is a suspicion of pulmonary TB. A computed tomography (CT) scan provides more accurate information on the extent and distribution of pulmonary TB. We present here a young, immunocompetent male patient with unusual imaging findings for pulmonary TB. We discuss the clinical presentation and management.


Subject(s)
Cysts/diagnostic imaging , Tomography, X-Ray Computed , Tuberculoma/diagnostic imaging , Tuberculosis, Pulmonary/diagnostic imaging , Antitubercular Agents/therapeutic use , Combined Modality Therapy , Cysts/immunology , Cysts/microbiology , Cysts/therapy , Drug Therapy, Combination , Humans , Immunocompetence , Male , Mycobacterium tuberculosis/isolation & purification , Pneumonectomy , Thoracotomy , Treatment Outcome , Tuberculoma/immunology , Tuberculoma/microbiology , Tuberculoma/therapy , Tuberculosis, Pulmonary/immunology , Tuberculosis, Pulmonary/microbiology , Tuberculosis, Pulmonary/therapy , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...